Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
about
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPDDose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: one size does not fit allImpact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adultsOutcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalenceUse of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic reviewHIV-Associated TB in An Giang Province, Vietnam, 2001–2004: Epidemiology and TB Treatment OutcomesTreatment outcomes of patients co-infected with tuberculosis and HIV at Chiang Mai University Hospital, ThailandHIV and Tuberculosis: a Deadly Human SyndemicHIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational studyLinking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India.Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis.HIV-specific health care utilization and mortality among tuberculosis/HIV coinfected persons.Patients diagnosed with tuberculosis at death or who died during therapy: association with the human immunodeficiency virusElevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention.The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort studyEffect of pulmonary tuberculosis on mortality in patients receiving HAART.Outcome of tuberculosis treatment and its predictors among HIV infected patients in southwest Ethiopia.Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania.Treatment Options for HIV-Associated Tuberculosis.Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand.Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort studyAntiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluidGlobal control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisTreatment outcome and mortality at one and half year follow-up of HIV infected TB patients under TB control programme in a district of South IndiaThe impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis.Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi.Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimenContribution of N-glucuronidation to efavirenz elimination in vivo in the basal and rifampin-induced metabolism of efavirenz.Initiating antiretrovirals during tuberculosis treatment: a drug safety review.Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi.Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study.Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy erasEfficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.The Effect of Early Initiation of Antiretroviral Therapy in TB/HIV-Coinfected Patients: A Systematic Review and Meta-Analysis.Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort.Treatment outcomes of patients with HIV and tuberculosis.HIV status determination among tuberculosis patients from California during 2008.
P2860
Q22241773-9A7E9BAC-32AC-49F4-AF61-ED694856DDE0Q24609011-F6B1B3C5-770C-49D7-A80C-A1AD9222CD5FQ28469286-AA053CF5-3629-4DCC-85E2-C133B6B3ADDDQ28472258-6939B6CC-191C-4A1F-A044-2A408C6ACB79Q28479241-04EC4B43-4EFD-40C9-A680-B7AE1CA4772DQ28484857-74659A2B-1D9D-4C2F-B79D-E2A3C6FCDC51Q30047301-7AF284F0-CACA-47FE-B800-C7B6AC2DE976Q30051056-3DCC73BF-F30F-4E80-BF56-1FFD04A4339BQ30052157-E3C784FA-1EA0-4794-8082-95DB2966F1CFQ33429719-519D9A9D-25A7-4B19-9AA1-D0F174530BF0Q33471454-021116CC-7331-4C76-B11E-B9B4C4727077Q33515849-33EB1599-3E0C-4821-B3DD-36BC2742F282Q33705696-C62BD288-2750-4BE3-97C5-84CEA1A33005Q33746063-8708EDE8-A659-4391-BBE3-4DA7F0A64DE7Q33757222-5BAA4280-A56B-426D-9ED1-CBE57496ACFCQ33758612-C60306B0-CB02-4F70-BFB1-0C40AEA97A86Q33764880-A5695039-81DA-4447-9880-5904EED661EBQ33806776-ADEB3A72-3265-48C5-997A-02EB43E31219Q33807615-C037F0AB-AB59-470E-8383-7E1B94407E11Q33813097-A9334C19-3EB7-4E5F-9376-D941F82C3026Q33884068-80AB4231-A1C7-469A-8370-3F7187C514BEQ33894801-514153C1-91C6-47A9-B249-0E2976182ACFQ33920318-CE8B7A79-1B41-473F-82E4-669596526262Q33924841-0E3CCCA2-4902-4C44-A219-DD503B91BC6EQ33926262-035EE897-0CCE-4E36-A47D-5F84A3C564F5Q33981349-7688B3CD-09B9-457C-B85C-52C68940E53AQ34497528-EB125ADF-2174-49EF-9A80-B6D26EA6999CQ34606640-F32625F1-A80F-40A4-BF87-C01ECC3AC301Q34699201-26FDEA17-9E10-4F78-9BCE-D461C31B4899Q34737523-70CB1495-98A8-42DD-A35B-4F163CFA4A24Q35043048-4544F363-9020-4CAC-BEBA-46F726B531D5Q35098738-8058E5E7-78AE-4453-9C09-6C2692638343Q35114820-44F542E9-2309-42BE-8B96-4106A94ED340Q35121804-61DCD5DF-3B49-4A23-877C-63CD79C59532Q35494596-FEBA1FC3-A355-43E6-8E5D-EE052E50C883Q35598520-0F9647BC-8142-4777-88BC-033B1C4BFC92Q35750657-7B77D958-4182-4399-B48D-9D95FC443F3CQ35835660-B98E4249-F988-4FE0-B9DF-1A01EACB60ADQ35855154-51774831-6470-4495-B8CD-5D08C09A02DBQ36036710-BE1E941F-7FC3-43AB-A899-0F210ED7F970
P2860
Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Outcome of HIV-associated tube ...... active antiretroviral therapy.
@en
Outcome of HIV-associated tube ...... active antiretroviral therapy.
@nl
type
label
Outcome of HIV-associated tube ...... active antiretroviral therapy.
@en
Outcome of HIV-associated tube ...... active antiretroviral therapy.
@nl
prefLabel
Outcome of HIV-associated tube ...... active antiretroviral therapy.
@en
Outcome of HIV-associated tube ...... active antiretroviral therapy.
@nl
P2093
P356
P1476
Outcome of HIV-associated tube ...... active antiretroviral therapy.
@en
P2093
Fiona C Lampe
Marc C Lipman
Margaret A Johnson
P304
P356
10.1086/424676
P407
P577
2004-09-29T00:00:00Z